These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27364101)

  • 1. An objective Bayesian analysis of a crossover design via model selection and model averaging.
    Li D; Sivaganesan S
    Stat Med; 2016 Nov; 35(25):4509-4527. PubMed ID: 27364101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model averaging for treatment effect estimation in subgroups.
    Bornkamp B; Ohlssen D; Magnusson BP; Schmidli H
    Pharm Stat; 2017 Mar; 16(2):133-142. PubMed ID: 27935199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective.
    Kruschke JK; Liddell TM
    Psychon Bull Rev; 2018 Feb; 25(1):178-206. PubMed ID: 28176294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accounting for uncertainty in the historical response rate of the standard treatment in single-arm two-stage designs based on Bayesian power functions.
    Matano F; Sambucini V
    Pharm Stat; 2016 Nov; 15(6):517-530. PubMed ID: 27766770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective Bayesian model selection for Cox regression.
    Held L; Gravestock I; Sabanés Bové D
    Stat Med; 2016 Dec; 35(29):5376-5390. PubMed ID: 27580645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian effect estimation accounting for adjustment uncertainty.
    Wang C; Parmigiani G; Dominici F
    Biometrics; 2012 Sep; 68(3):661-71. PubMed ID: 22364439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis of Bayesian adaptive crossover trials for evaluating contact lens safety and efficacy.
    Zhang Q; Toubouti Y; Carlin BP
    Stat Methods Med Res; 2017 Jun; 26(3):1216-1236. PubMed ID: 25698715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of parameter uncertainty for an activated sludge model using Bayesian inference: a comparison with the frequentist method.
    Zonta ZJ; Flotats X; Magrí A
    Environ Technol; 2014 Aug; 35(13-16):1618-29. PubMed ID: 24956752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian methods of confidence interval construction for the population attributable risk from cross-sectional studies.
    Pirikahu S; Jones G; Hazelton ML; Heuer C
    Stat Med; 2016 Aug; 35(18):3117-30. PubMed ID: 26799685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of N-of-1 trials using Bayesian distributed lag model with autocorrelated errors.
    Liao Z; Qian M; Kronish IM; Cheung YK
    Stat Med; 2023 Jun; 42(13):2044-2060. PubMed ID: 36762453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the minimum effective dose for normally distributed data using a Bayesian variable selection approach.
    Otava M; Shkedy Z; Hothorn LA; Talloen W; Gerhard D; Kasim A
    J Biopharm Stat; 2017; 27(6):1073-1088. PubMed ID: 28328286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian robustness in meta-analysis for studies with zero responses.
    Vázquez FJ; Moreno E; Negrín MA; Martel M
    Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiparametric time varying coefficient model for matched case-crossover studies.
    Ortega-Villa AM; Kim I; Kim H
    Stat Med; 2017 Mar; 36(6):998-1013. PubMed ID: 27976418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting the results of clinical trials, embracing uncertainty: A Bayesian approach.
    Frost SA; Alexandrou E; Schulz L; Aneman A
    Acta Anaesthesiol Scand; 2021 Feb; 65(2):146-150. PubMed ID: 33051864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian approach to mitigation of publication bias.
    Guan M; Vandekerckhove J
    Psychon Bull Rev; 2016 Feb; 23(1):74-86. PubMed ID: 26126776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian analysis of the two-period crossover design for clinical trials.
    Grieve AP
    Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian approach to sequential meta-analysis.
    Spence GT; Steinsaltz D; Fanshawe TR
    Stat Med; 2016 Dec; 35(29):5356-5375. PubMed ID: 27481499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed Bayesian survival analysis.
    Bartoš F; Aust F; Haaf JM
    BMC Med Res Methodol; 2022 Sep; 22(1):238. PubMed ID: 36088281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian reclassification statistics for assessing improvements in diagnostic accuracy.
    Huang Z; Li J; Cheng CY; Cheung C; Wong TY
    Stat Med; 2016 Jul; 35(15):2574-92. PubMed ID: 26875442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.